What can we help you find?
Pharmacy Times spoke with Jessica Langley, MS, executive director of education and advocacy of NHA, about how the pandemic has changed the pharmacy technician industry and advice for future pharmacy technician opportunities.
Although transfering the annual event to a virtual format presented challenges, NASP President and CEO Sheila Arquette, RPh, said she is excited to connect with attendees just as much as in previous years.
Experts in the field of breast cancer management review the data from the ExteNET and TRAIN-2 Trials.
As accessible health care providers, pharmacists are in a great position to spread much-needed information.
Two experts discuss proper treatment for peripheral artery disease (PAD) and coronary artery disease (CAD).
Moss will soon begin offering weekly social media tips and tricks in live events on the Pharmacy Times Facebook and Instagram pages, with topics such as finding your niche, creating content, and planning ahead on social media platforms.
Pharmacists in the breast cancer field discuss the role for disease-free survival as an end point and the implications of the KATHERINE trial.
Cardiovascular panel of experts provide an overview and mechanism of action for the direct oral anticoagulants.
Pharmacy Times spoke with Ron Lanton, Principal at Lanton Law, about Rutledge v. PCMA and its impact on pharmacy and PBMs.
This Pharmacy Times Webcast provides an overview of how the COVID-19 pandemic has impacted the treatment and management of patients with cancer.
Congress is in the middle of discussing this issue, Hogue said, meaning pharmacists need to advocate for provider status immediately.
Advancements in Treatment and Management of HER2-Positive Early Breast Cancer: Introduction and the APHINITY Trial
Jacob Kettle, PharmD, BCOP, and Allison Butts, PharmD, BCOP, share insights on some recent trials for early stage breast cancer, specifically the APHINITY trial.